The Effect of Antihelminthic Treatment on Subjects with Asthma from an Endemic Area of Schistosomiasis: A Randomized, Double-Blinded, and Placebo-Controlled Trial

Table 1

Baseline characteristics of studied subjects.

	Group 1 placebo 𝑛=20	Group 2 Praziquantel 𝑛=25	𝑃 value
Gender 𝑛
Male 𝑛 (%)	10 (50)	8 (32)	>0.05
Female 𝑛 (%)	10 (50)	17 (68)
Age group 𝑛 (%)
Child/teenagers (6–20 years old)	12 (65)	18 (72)	>0.05
Adult (21–50 years old)	8 (35)	7 (28)	>0.05
Rhinitis 𝑛 (%)	10 (50)	18 (72)	>0.05
Smoking 𝑛 (%)
Active	6 (30)	7 (28)	>0.05
Passive	18 (90)	9 (36)	<0.005
Positive SPT response 𝑛 (%)
Dermatophagoides pteronyssinus	2 (10)	5 (20)	>0.05
D. farinae	2 (10)	5 (20)	>0.05
Blomia tropicalis	4 (20)	7 (28)	>0.05
Periplaneta americana	1 (5)	3 (12)	>0.05
Blatella germanica	2 (10)	3 (12)	>0.05
Positive total	9 (45)	9 (36)	>0.05
Current helminth infections 𝑛 (%)
Schistosoma mansoni	16 (80)	19 (76)	>0.05
Ascaris lumbricoides	10 (50)	14 (56)	>0.05
Hookworm	7 (35)	10 (40)	>0.05
Trichuris trichiura	10 (50)	13 (52)	>0.05
Coinfection (S. mansoni /1 or + helminths)	14 (90)	19 (100)	>0.05